Laparoscopic Salpingostomy versus Methotrexate for Treatment of Undisturbed Tubal Ectopic Pregnancy | ||
| Zagazig University Medical Journal | ||
| Article 19, Volume 30, Issue 1, January and February 2024, Pages 187-198 PDF (1.23 M) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/zumj.2023.182654.2704 | ||
| Authors | ||
| Hawwa Ahmed Ibraheem* 1; Mohamed Lotfy Mohamed El Sayed2; Waeel Sabry Nosser2; Ahmed Elsayed Mansour2 | ||
| 1Department of Obstetrics & Gynecology, Faculty of Medicine, Omar Al-Mukhter University- Libya | ||
| 2Department of Obstetrics & Gynecology, Faculty of Medicine, Zagazig University, Egypt | ||
| Abstract | ||
| Background: Laparoscopic salpingotomy is a well-established treatment for patients with tubal pregnancy who desire to retain fertility. Another approach that preserves the fallopian tube is medical treatment. This study aimed to evaluate the safety and efficacy of laparoscopic versus MTX treatment of well-selected cases of undisturbed ectopic pregnancy. Patients and methods: patients were divided into first group; 30 cases of undisturbed tubal pregnancy treated by MXT therapy. (25cases) by single dose and (5cases) by second dose: single dose regimen (MTX 50mg /m² IM) and second dose regimen. (MTX 50mg /m²IM) on 7th day. Second group; 30 cases of undisturbed tubal pregnancy treated by laparoscopic salpingostomy. Tubal patency tested after 8 weeks for all cases by hysterosalpingography. Outcome measures were treatment success, tubal preservation, homolateral tubal patency, and fertility potential after each treatment protocol. Results: There was a statistically significant higher frequency of tubal patency in methotrexate group compared to laparoscopic salpingostomy group, with p-value (p=0.007). Conclusions: Methotrexate is better than laparoscopic salpingostomy in treating undisturbed tubal pregnancy | ||
| Keywords | ||
| Laparoscopy; Methotrexate; Tubal pregnancy; Laparoscopic salpingostomy | ||
|
Statistics Article View: 227 PDF Download: 213 |
||
